Drug profile · INN
estradiol acetate
FEMRING
estradiol acetate (FEMRING) is a estrogen receptor alpha agonist. Route of administration: vaginal. Current US regulatory status: approved.
Drug details — estradiol acetate
- US status
- approved
- Class
- —
- Route
- VAGINAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
estradiol acetate (FEMRING) is a estrogen receptor alpha agonist. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor alpha agonist
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is estradiol acetate?
estradiol acetate (FEMRING) is a estrogen receptor alpha agonist. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for estradiol acetate?
FEMRING is a marketed brand name for estradiol acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of estradiol acetate?
estradiol acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.